You are here

Article Text

Article menu
Download PDFPDF
Letter
When gravimetry is debated by sponsors of clinical studies
  1. Aline Voidey1,2,
  2. Isabelle Sommer1,2,
  3. Alessia Marino1,2,
  4. Laurent Carrez1,2,
  5. Farshid Sadeghipour1,2
  1. 1Pharmacy, CHUV, Lausanne, Switzerland
  2. 2Center for Research and Innovation in Clinical Pharmaceutical Sciences, University of Lausanne, Lausanne, Switzerland
  1. Correspondence to Dr Aline Voidey, Pharmacy, CHUV, lausanne, Switzerland; aline.voidey{at}chuv.ch

https://doi.org/10.1136/ejhpharm-2024-004153

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Cancer research has grown significantly in recent years with the advent of targeted therapies and immunotherapies. Hospital pharmacies with clinical trials and production units need to manage and produce these new drugs. Unlike the industry, where processes are automated, hospital pharmacy processes are often manual. The flow of these experimental drugs should be secured.1 Hospital pharmacies can choose from several production in-process control methods, the most common of which is human-visual double-checking or computer-assisted preparation with automated visual control by camera or automated gravimetric control by connected scales.

    This method, which uses computer-assisted double-checking, has …

    View Full Text

    Footnotes

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.